Fragile X Syndrome Overview and the CONNECT-FX Clinical Trial



Armando Anido, Chief Executive Officer at Zynerba Pharmaceuticals discusses Fragile X syndrome, a genetic condition involving changes in part of the X …

Be the first to comment

Leave a Reply

Your email address will not be published.


*